ABCL
Price
$13.73
Change
-$0.18 (-1.29%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
4.51B
39 days until earnings call
Intraday BUY SELL Signals
OABI
Price
$4.87
Change
-$0.13 (-2.61%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
689.15M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs OABI

ABCL vs OABI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. OABI commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and OABI is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ABCLOABI
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 23 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
47%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (ABCL: $13.91 vs. OABI: $4.99)
Brand notoriety: ABCL and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 117% vs. OABI: 125%
Market capitalization -- ABCL: $4.51B vs. OABI: $689.15M
ABCL [@Biotechnology] is valued at $4.51B. OABI’s [@Biotechnology] market capitalization is $689.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green while OABI’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, OABI is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while OABI’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • OABI’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than OABI.

Price Growth

ABCL (@Biotechnology) experienced а +9.96% price change this week, while OABI (@Biotechnology) price change was +4.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 10, 2026.

OABI is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABCL
Daily Signal:
Gain/Loss:
OABI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SEMY12.650.08
+0.64%
GraniteShares YieldBOOST Semiconductor ETF (SEMY)
THRV23.30-0.03
-0.13%
Prospera Income ETF (THRV)
SIL85.63-0.38
-0.44%
Global X Silver Miners ETF (SIL)
GRX9.42-0.09
-0.95%
Gabelli Healthcare & Wellness Trust (The)
HEZU47.96-0.48
-0.99%
iShares Currency Hedged MSCI Eurozone ETF (HEZU)

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-4.66%
RXRX - ABCL
59%
Loosely correlated
-1.45%
ABSI - ABCL
56%
Loosely correlated
-0.19%
VCYT - ABCL
56%
Loosely correlated
-4.02%
CRSP - ABCL
54%
Loosely correlated
+0.22%
EDIT - ABCL
51%
Loosely correlated
-1.95%
More

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+0.60%
VCYT - OABI
37%
Loosely correlated
-4.02%
TRDA - OABI
35%
Loosely correlated
-10.55%
CELC - OABI
33%
Poorly correlated
-5.52%
ABCL - OABI
33%
Poorly correlated
-4.66%
BCYC - OABI
32%
Poorly correlated
-3.26%
More